Share Price | Alpha Tau Medical Ltd. Stock Analysis & Recommendation

Q: Is Alpha Tau Medical Ltd. technically bullish or bearish?

As of 21 August 2025, the technical trend for Alpha Tau Medical Ltd. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages are also bullish, indicating positive momentum. However, the weekly RSI is bearish, which suggests some short-term weakness. The Bollinger Bands show a mildly bullish stance on the weekly and a bullish stance on the monthly. The KST and OBV are bullish on both weekly and monthly time frames, reinforcing the overall bullish sentiment.In terms of performance, Alpha Tau Medical Ltd. has significantly outperformed the S&P 500 over the past month (16.87% vs. 2.33%) and the past year (63.52% vs. 17.14%), although it has underperformed over the last three years (-37.44% vs. 70.41%). Overall, the current technical stance is bullish, with strong indicators supporting this view.

Q: What does Alpha Tau Medical Ltd. do?

Overview:Alpha Tau Medical Ltd. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.Financial Snapshot:Net Profit: -9 Million (Quarterly Results - Mar 2025) Market Cap: USD 250.71 Million (Micro Cap)Key Metrics:P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -0.86 Return on Equity: -57.63% Price to Book: 4.45 Contact Details:Details: No Company Details Available Registrar Address: Not available.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

264.26 k

Shareholding (Jun 2026)

FII

1.53%

Held by 16 FIIs

DII

98.47%

Held by 1 DIIs

Promoter

0.00%

Is Alpha Tau Medical Ltd. technically bullish or bearish?

20-Sep-2025

As of August 21, 2025, Alpha Tau Medical Ltd. shows a bullish technical trend with strong indicators, despite a bearish weekly RSI, having outperformed the S&P 500 significantly over the past month and year, while underperforming over the last three years.

View full answer

How big is Alpha Tau Medical Ltd.?

22-Jun-2025

As of Jun 18, Alpha Tau Medical Ltd. has a market capitalization of 250.71 million and reported net sales of 0.00 million with a net profit of -32.46 million over the last four quarters. The balance sheet shows shareholder's funds of 62.67 million and total assets of 86.20 million.

View full answer

What does Alpha Tau Medical Ltd. do?

22-Jun-2025

Alpha Tau Medical Ltd. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $9 million and a market cap of $250.71 million. Key financial metrics include a negative P/E ratio, a 0.00% dividend yield, and a return on equity of -57.63%.

View full answer

Compare Alpha Tau Medical Ltd. with Similar Stocks

Accuray, Inc.Sanara MedTech, Inc.Anika Therapeutics, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 604 Million (Small Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.90

Return on Equity

-55.29%

Price to Book

7.83

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2026)

Net Profit:

-46 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

61.19%

6 Months

107.36%

1 Year

303.39%

2 Years

570.56%

3 Years

356.93%

4 Years

154.35%

5 Years

56.78%

Alpha Tau Medical Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-300.23%

EBIT to Interest (avg)

-29.31

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.86

Sales to Capital Employed (avg)

Tax Ratio

0.32%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

5.25%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

7.83

EV to EBIT

-12.64

EV to EBITDA

-12.64

EV to Capital Employed

69.58

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-550.70%

ROE (Latest)

-55.29%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2026

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 4 Schemes (0.46%)

Foreign Institutions

Held by 16 Foreign Institutions (1.53%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Jun 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is -353.47% vs -36.49% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-13.80",
          "val2": "-9.60",
          "chgp": "-43.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "31.80",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-45.80",
          "val2": "-10.10",
          "chgp": "-353.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -34.38% vs -8.56% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-41.10",
          "val2": "-34.90",
          "chgp": "-17.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.30",
          "chgp": "33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.00",
          "val2": "0.30",
          "chgp": "-766.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-42.60",
          "val2": "-31.70",
          "chgp": "-34.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY

Jun'26

Jun'25

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-13.80

-9.60

-43.75%

Interest

31.80

0.00

Exceptional Items

0.00

Consolidate Net Profit

-45.80

-10.10

-353.47%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Jun 2025

Consolidated Net Profit

YoY Growth in quarter ended Jun 2026 is -353.47% vs -36.49% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-41.10

-34.90

-17.77%

Interest

0.40

0.30

33.33%

Exceptional Items

-2.00

0.30

-766.67%

Consolidate Net Profit

-42.60

-31.70

-34.38%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -34.38% vs -8.56% in Dec 2024

All Annual Results

Company CV

About Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available